Search Results - "Miglietta, D"
-
1
P.11.2 Naproxcinod, a nitric oxide-donating anti-inflammatory compound, is effective in two mouse models of muscle dystrophy
Published in Neuromuscular disorders : NMD (01-10-2013)“…Nitric oxide (NO) plays a critical role in skeletal muscle function, including control of blood flow and muscle repair. In muscular dystrophies, synthesis of…”
Get full text
Journal Article -
2
571 NAPROXCINOD UNLIKE NAPROXEN INHIBITS EXPRESSION OF iNOS IN ACTIVATED MACROPHAGES IN VITRO
Published in Osteoarthritis and cartilage (2010)Get full text
Journal Article -
3
P.11.3 Long term treatment with naproxcinod significantly improves skeletal and cardiac function in mdx mouse model of dystrophy
Published in Neuromuscular disorders : NMD (01-10-2013)“…There is evidence that nitric oxide (NO) plays a critical role in skeletal muscle. In Duchenne muscular dystrophy (DMD) patients and the mdx mouse model of…”
Get full text
Journal Article -
4
-
5
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy
Published in Human molecular genetics (15-06-2014)“…In Duchenne muscular dystrophy (DMD) patients and the mouse model of DMD, mdx, dystrophin deficiency causes a decrease and mislocalization of muscle-specific…”
Get full text
Journal Article -
6
NAPROXCINOD COUNTERBALANCES VASOCONSTRICTION DUE TO COX INHIBITION IN HUMAN ARTERIES WITH ENDOTHELIAL DYSFUNCTION: PP.6.253
Published in Journal of hypertension (01-06-2010)Get full text
Journal Article -
7
765 NITRIC OXIDE-DONATING STATINS EXERT BENEFICIAL EFFECTS ON ACUTE VASCULAR INFLAMMATION IN NORMOCHOLESTEROLEMIC RABBITS
Published in Atherosclerosis. Supplements (01-06-2011)Get full text
Journal Article -
8
-
9
Obesity: an always present problem
Published in La Rassegna di clinica, terapia e scienze affini (1966)Get more information
Journal Article